Kenvue Inc.
Market cap $34.3B
$17.89
KVUE
$17.89
+0.09% today
Buy with €1M virtual cash · No real money
Kenvue Inc. (KVUE) is a publicly traded company listed on the XNYS. As of September 18, 2026, Invest's signal rates KVUE a Hold, with the stock down 2% over the past year. You can practice trading KVUE risk-free with €1,000,000 in virtual cash.
Key stats
As of September 18, 2026
Market Cap
$34.3B
Volume
3.7M
52-wk High
$20.13
52-wk Low
$14.02
Day High
$17.90
Day Low
$17.76
P/E (TTM)
20.56
Revenue (TTM)
$15.4B
EPS (TTM)
$0.87
Performance
1M
-6.5%
6M
+2.6%
1Y
-2.5%
Invest signal · KVUE
HoldAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
KVUE overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev +1.2%Revenue
$4BEPS (diluted)
$0.24 per shareLatest KVUE news
Here's My Pick for the Smartest High-Yield Dividend Stock to Buy Right Now
The Motley Fool · 3d ago
Kimberly Clark is Down 20% From Its 52-Week High. Is the Dip Worth Buying?
The Motley Fool · 6d ago
Kenvue's Kimberly-Clark Deal Nears Closing With Key Risks Still Ahead
Zacks Investment Research · Sep 7
Should Investors Buy KVUE as Margin Gains Offset Slow Sales Growth?
Zacks Investment Research · Sep 7
Global Skin Care Products Market is Expected to Surpass the USD 260 Billion Mark by 2034 | DelveInsight
GlobeNewswire Inc. · Sep 2
About Kenvue Inc.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health.
Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
Employees
22,000
30-Day Win Rate · KVUE
10 days
14 days
Last 24 sessions
How to practice trading KVUE
- 1
Use the KVUE buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top KVUE traders on Invest
Full leaderboardFrequently asked questions
Is KVUE a good stock to buy right now?
As of September 18, 2026, Invest's signal rates KVUE a Hold, based on its price trend, valuation, and fundamentals (P/E around 20.6), with the stock down 2% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading KVUE risk-free first.
What is Kenvue Inc.'s (KVUE) market cap?
Kenvue Inc. has a market capitalization of approximately $34.3B, on trailing-twelve-month revenue of about $15.4B.
How has KVUE stock performed?
KVUE is down 2% over the past year and up 3% over six months. Its 52-week range runs roughly from $14.02 to $20.13. Past performance doesn't predict future results.
How can I practice trading KVUE for free?
On Invest you get €1,000,000 in virtual cash and can buy KVUE at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare KVUE with peers